Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Resolution of Chlamydia trachomatis Infection Is Associated with a Distinct T Cell Response Profile.

Picard MD, Bodmer JL, Gierahn TM, Lee A, Price J, Cohane K, Clemens V, DeVault VL, Gurok G, Kohberger R, Higgins DE, Siber GR, Flechtner JB, Geisler WM.

Clin Vaccine Immunol. 2015 Nov;22(11):1206-18. doi: 10.1128/CVI.00247-15. Epub 2015 Oct 7.

2.

Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian children in the second year of life.

Bhandari N, Rongsen-Chandola T, Bavdekar A, John J, Antony K, Taneja S, Goyal N, Kawade A, Kang G, Rathore SS, Juvekar S, Muliyil J, Arya A, Shaikh H, Abraham V, Vrati S, Proschan M, Kohberger R, Thiry G, Glass R, Greenberg HB, Curlin G, Mohan K, Harshavardhan GV, Prasad S, Rao TS, Boslego J, Bhan MK; India Rotavirus Vaccine Group.

Vaccine. 2014 Aug 11;32 Suppl 1:A110-6. doi: 10.1016/j.vaccine.2014.04.079.

3.

Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial.

Bhandari N, Rongsen-Chandola T, Bavdekar A, John J, Antony K, Taneja S, Goyal N, Kawade A, Kang G, Rathore SS, Juvekar S, Muliyil J, Arya A, Shaikh H, Abraham V, Vrati S, Proschan M, Kohberger R, Thiry G, Glass R, Greenberg HB, Curlin G, Mohan K, Harshavardhan GV, Prasad S, Rao TS, Boslego J, Bhan MK; India Rotavirus Vaccine Group.

Lancet. 2014 Jun 21;383(9935):2136-43. doi: 10.1016/S0140-6736(13)62630-6. Epub 2014 Mar 12.

4.

Evaluation of safety and immunogenicity of recombinant influenza hemagglutinin (H5/Indonesia/05/2005) formulated with and without a stable oil-in-water emulsion containing glucopyranosyl-lipid A (SE+GLA) adjuvant.

Treanor JJ, Essink B, Hull S, Reed S, Izikson R, Patriarca P, Goldenthal KL, Kohberger R, Dunkle LM.

Vaccine. 2013 Nov 19;31(48):5760-5. doi: 10.1016/j.vaccine.2013.08.064. Epub 2013 Sep 27.

PMID:
24075920
5.

Anthrax vaccine-induced antibodies provide cross-species prediction of survival to aerosol challenge.

Fay MP, Follmann DA, Lynn F, Schiffer JM, Stark GV, Kohberger R, Quinn CP, Nuzum EO.

Sci Transl Med. 2012 Sep 12;4(151):151ra126. doi: 10.1126/scitranslmed.3004073.

6.

Economic burden of acute lower respiratory tract infection in South African children.

Sinha A, Kim S, Ginsberg G, Franklin H, Kohberger R, Strutton D, Madhi SA, Griffiths UK, Klugman KP.

Paediatr Int Child Health. 2012 May;32(2):65-73. doi: 10.1179/2046905512Y.0000000010.

PMID:
22595212
7.

Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: a randomized, placebo-controlled trial.

Treanor JJ, El Sahly H, King J, Graham I, Izikson R, Kohberger R, Patriarca P, Cox M.

Vaccine. 2011 Oct 13;29(44):7733-9. doi: 10.1016/j.vaccine.2011.07.128. Epub 2011 Aug 9.

PMID:
21835220
8.

Predictive models and correlates of protection for testing biodefence vaccines.

Williamson ED, Duchars MG, Kohberger R.

Expert Rev Vaccines. 2010 May;9(5):527-37. doi: 10.1586/erv.10.22. Review.

PMID:
20450327
9.

Comments on 'Sample size for equivalence trials: A case study from a vaccine lot consistency trial' by J. Ganju, A. Izu and A. Anemona, Statistics in Medicine 2008; 27:3743-3754.

Kohberger RC.

Stat Med. 2009 Jan 15;28(1):177-8, author reply 178-9. doi: 10.1002/sim.3443. No abstract available.

PMID:
18937271
10.

Immunogenicity and serotype-specific efficacy of a 9-valent pneumococcal conjugate vaccine (PCV-9) determined during an efficacy trial in The Gambia.

Saaka M, Okoko BJ, Kohberger RC, Jaffar S, Enwere G, Biney EE, Oluwalana C, Vaughan A, Zaman SM, Asthon L, Goldblatt D, Greenwood BM, Cutts FT, Adegbola RA.

Vaccine. 2008 Jul 4;26(29-30):3719-26. doi: 10.1016/j.vaccine.2008.04.066. Epub 2008 May 16.

PMID:
18514974
11.

Prediction of pertussis vaccine efficacy using a correlates of protection model.

Kohberger RC, Jemiolo D, Noriega F.

Vaccine. 2008 Jun 25;26(27-28):3516-21. doi: 10.1016/j.vaccine.2008.04.016. Epub 2008 Apr 28.

PMID:
18495303
12.

Predictors of pneumococcal conjugate vaccine immunogenicity among infants and toddlers in an American Indian PnCRM7 efficacy trial.

O'Brien KL, Moisi J, Moulton LH, Madore D, Eick A, Reid R, Weatherholtz R, Millar E, Hu D, Hackell J, Kohberger R, Siber G, Santosham M.

J Infect Dis. 2007 Jul 1;196(1):104-14. Epub 2007 May 24.

PMID:
17538890
13.

Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies.

Siber GR, Chang I, Baker S, Fernsten P, O'Brien KL, Santosham M, Klugman KP, Madhi SA, Paradiso P, Kohberger R.

Vaccine. 2007 May 10;25(19):3816-26. Epub 2007 Feb 21.

PMID:
17368878
14.

Design of vaccine equivalence/non-inferiority trials with correlated multiple binomial endpoints.

Kong L, Kohberger RC, Koch GG.

J Biopharm Stat. 2006;16(4):555-72.

PMID:
16892913
15.

Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children.

Vesikari T, Karvonen AV, Majuri J, Zeng SQ, Pang XL, Kohberger R, Forrest BD, Hoshino Y, Chanock RM, Kapikian AZ.

J Infect Dis. 2006 Aug 1;194(3):370-6. Epub 2006 Jun 23.

PMID:
16826486
16.
17.
18.

A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection.

Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N, Pierce N; Vaccine Trialists Group.

N Engl J Med. 2003 Oct 2;349(14):1341-8.

19.

Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial.

O'Brien KL, Moulton LH, Reid R, Weatherholtz R, Oski J, Brown L, Kumar G, Parkinson A, Hu D, Hackell J, Chang I, Kohberger R, Siber G, Santosham M.

Lancet. 2003 Aug 2;362(9381):355-61.

PMID:
12907008
20.

Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants.

Jódar L, Butler J, Carlone G, Dagan R, Goldblatt D, Käyhty H, Klugman K, Plikaytis B, Siber G, Kohberger R, Chang I, Cherian T.

Vaccine. 2003 Jul 4;21(23):3265-72. Review.

PMID:
12804857
21.

Design of a group-randomized Streptococcus pneumoniae vaccine trial.

Moulton LH, O'Brien KL, Kohberger R, Chang I, Reid R, Weatherholtz R, Hackell JG, Siber GR, Santosham M.

Control Clin Trials. 2001 Aug;22(4):438-52.

PMID:
11514043
22.

Efficacy of a pneumococcal conjugate vaccine against acute otitis media.

Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E, Takala A, Käyhty H, Karma P, Kohberger R, Siber G, Mäkelä PH; Finnish Otitis Media Study Group.

N Engl J Med. 2001 Feb 8;344(6):403-9.

23.

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group.

Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, Elvin L, Ensor KM, Hackell J, Siber G, Malinoski F, Madore D, Chang I, Kohberger R, Watson W, Austrian R, Edwards K.

Pediatr Infect Dis J. 2000 Mar;19(3):187-95.

PMID:
10749457
24.

Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers.

Shinefield HR, Black S, Ray P, Chang I, Lewis N, Fireman B, Hackell J, Paradiso PR, Siber G, Kohberger R, Madore DV, Malinowski FJ, Kimura A, Le C, Landaw I, Aguilar J, Hansen J.

Pediatr Infect Dis J. 1999 Sep;18(9):757-63.

PMID:
10493334
25.

Morphometric measurements and RNA content of axotomized feline cervical motoneurons.

Barron KD, Cova J, Scheibly ME, Kohberger R.

J Neurocytol. 1982 Oct;11(5):707-20.

PMID:
6183404
26.

Statistical evaluation of the direct linear plot method for estimation of enzyme kinetic parameters.

Kohberger RC.

Anal Biochem. 1980 Jan 1;101(1):1-6. No abstract available.

PMID:
7356119
27.

Cytologic observations on axotomized feline Betz cells. II. Quantitative ultrastructural findings.

Dentinger MP, Barron KD, Kohberger RC, McLean B.

J Neuropathol Exp Neurol. 1979 Sep;38(5):551-64.

PMID:
224151
28.

Hypnotic treatment of smoking: the single-treatment method revisited.

Berkowitz B, Ross-Townsend A, Kohberger R.

Am J Psychiatry. 1979 Jan;136(1):83-5.

PMID:
758833
29.

Resistant ascites in alcoholic liver cirrhosis: course and prognosis.

Capone RR, Buhac I, Kohberger RC, Balint JA.

Am J Dig Dis. 1978 Oct;23(10):867-71.

PMID:
717345

Supplemental Content

Loading ...
Support Center